Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary M Green

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 4, 2006
Endogenous cholecystokinin reduces food intake and increases Fos-like immunoreactivity in the dorsal vagal complex but not in the myenteric plexus by CCK1 receptor in the adult ratCherese N Sullivan, Shannon J Raboin, Stephen Gulley, et al.
Brain Research|March 19, 2008
Cholecystokinin-33 is more effective than cholecystokinin-8 in inhibiting food intake and in stimulating the myenteric plexus and dorsal vagal complexMarvis S Cooper, Joseph R Reeve, Mohamed O Abdalla, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 8, 2003
Differential bile-pancreatic secretory effects of CCK-58 and CCK-8Joseph R Reeve, S Vincent Wu, David A Keire, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 10, 2009
Cholecystokinin-58 and cholecystokinin-8 exhibit similar actions on calcium signaling, zymogen secretion, and cell fate in murine pancreatic acinar cellsDavid N Criddle, David M Booth, Rajarshi Mukherjee, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 26, 2009
Increased rates of appendicitis in HIV-infected men: 1991-2005Daniel B Klein, Leo B Hurley, Michael A Horberg, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 21, 2006
Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapyMichael A Horberg, Leo B Hurley, Daniel B Klein, et al.
MMWR. Morbidity and Mortality Weekly Report|June 16, 2017
Serious Bacterial Infections Acquired During Treatment of Patients Given a Diagnosis of Chronic Lyme Disease - United StatesNatalie S Marzec, Christina Nelson, Paul Ravi Waldron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2007
Progressive ORF virus infection in a patient with lymphoma: successful treatment using imiquimodEdith R Lederman, Gary M Green, Henry E DeGroot, et al.
Regulatory Peptides|April 11, 2003
Synthesis of biologically active canine CCK-58Joseph R Reeve, David A Keire, Tamer Coskun, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 6, 2004
Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological propertiesJoseph R Reeve, Rodger A Liddle, Douglas C McVey, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 4, 2006
Endogenous cholecystokinin reduces food intake and increases Fos-like immunoreactivity in the dorsal vagal complex but not in the myenteric plexus by CCK1 receptor in the adult ratCherese N Sullivan, Shannon J Raboin, Stephen Gulley, et al.
Brain Research|March 19, 2008
Cholecystokinin-33 is more effective than cholecystokinin-8 in inhibiting food intake and in stimulating the myenteric plexus and dorsal vagal complexMarvis S Cooper, Joseph R Reeve, Mohamed O Abdalla, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 8, 2003
Differential bile-pancreatic secretory effects of CCK-58 and CCK-8Joseph R Reeve, S Vincent Wu, David A Keire, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 10, 2009
Cholecystokinin-58 and cholecystokinin-8 exhibit similar actions on calcium signaling, zymogen secretion, and cell fate in murine pancreatic acinar cellsDavid N Criddle, David M Booth, Rajarshi Mukherjee, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 26, 2009
Increased rates of appendicitis in HIV-infected men: 1991-2005Daniel B Klein, Leo B Hurley, Michael A Horberg, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 21, 2006
Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapyMichael A Horberg, Leo B Hurley, Daniel B Klein, et al.
MMWR. Morbidity and Mortality Weekly Report|June 16, 2017
Serious Bacterial Infections Acquired During Treatment of Patients Given a Diagnosis of Chronic Lyme Disease - United StatesNatalie S Marzec, Christina Nelson, Paul Ravi Waldron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2007
Progressive ORF virus infection in a patient with lymphoma: successful treatment using imiquimodEdith R Lederman, Gary M Green, Henry E DeGroot, et al.
Regulatory Peptides|April 11, 2003
Synthesis of biologically active canine CCK-58Joseph R Reeve, David A Keire, Tamer Coskun, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 6, 2004
Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological propertiesJoseph R Reeve, Rodger A Liddle, Douglas C McVey, et al.
Pageof 3